[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小胡小瑞发布了新的文献求助10
1秒前
傅宛白发布了新的文献求助10
2秒前
2秒前
酷酷语兰完成签到,获得积分10
3秒前
3秒前
xyz完成签到,获得积分10
4秒前
Sou完成签到 ,获得积分10
4秒前
abcc1234完成签到,获得积分10
5秒前
Myvvt发布了新的文献求助10
5秒前
Ye666完成签到,获得积分10
5秒前
不安夜雪发布了新的文献求助10
6秒前
嗡嗡嗡发布了新的文献求助10
6秒前
琴楼完成签到,获得积分10
6秒前
33发布了新的文献求助30
8秒前
8秒前
鄂霸发布了新的文献求助10
8秒前
123发布了新的文献求助10
10秒前
852应助南北采纳,获得10
12秒前
赘婿应助小胡小瑞采纳,获得10
13秒前
左丘蛟凤发布了新的文献求助30
13秒前
yy完成签到,获得积分10
13秒前
李白南南完成签到 ,获得积分10
14秒前
14秒前
安静的博完成签到,获得积分10
15秒前
16秒前
17秒前
英俊的铭应助邦哥采纳,获得10
17秒前
丘比特应助花满楼采纳,获得10
18秒前
NexusExplorer应助Chen采纳,获得10
19秒前
533发布了新的文献求助10
20秒前
nozero应助飞翔的企鹅采纳,获得80
21秒前
21秒前
21秒前
Amikacin完成签到,获得积分10
21秒前
静静的旋律完成签到 ,获得积分10
22秒前
22秒前
25秒前
积木发布了新的文献求助10
25秒前
TRY发布了新的文献求助10
25秒前
123完成签到,获得积分10
25秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
中华人民共和国出版史料 6 1954年 500
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3814123
求助须知:如何正确求助?哪些是违规求助? 3358369
关于积分的说明 10394045
捐赠科研通 3075673
什么是DOI,文献DOI怎么找? 1689451
邀请新用户注册赠送积分活动 812897
科研通“疑难数据库(出版商)”最低求助积分说明 767404